share_log

Truist Securities Downgrades Treace Medical Concepts to Hold, Lowers Price Target to $7

Truist Securities Downgrades Treace Medical Concepts to Hold, Lowers Price Target to $7

信托证券将Treace Medical Concepts的评级下调至持有,将目标股价下调至7美元
Benzinga ·  05/08 08:47

Truist Securities analyst Richard Newitter downgrades Treace Medical Concepts (NASDAQ:TMCI) from Buy to Hold and lowers the price target from $17 to $7.

Truist Securities分析师理查德·内维特将Treace Medical Concepts(纳斯达克股票代码:TMCI)的评级从买入下调至持有,并将目标股价从17美元下调至7美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发